Cart
sales@molnova.com
Omalizumab
CAS No. 242138-07-4
Omalizumab( —— )
Catalog No. M22157 CAS No. 242138-07-4
Omalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 455 | In Stock |
|
| 10MG | 659 | In Stock |
|
| 25MG | 981 | In Stock |
|
| 50MG | 1341 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOmalizumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionOmalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE).
-
DescriptionOmalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number242138-07-4
-
Formula Weight149 kDa
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chan MA, et al.Omalizumab may decrease IgE synthesis by targeting membrane IgE+ human B cells.Clin Transl Allergy. 2013 Sep 2;3(1):29.
molnova catalog
related products
-
Glenzocimab
Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.
-
6-ROX
6-ROX is a fluorescent oligonucleotide marker and acts as an acceptor molecule coupled to 5-FAM as the donor in FRET imaging with excitation of 568nm and emission of 568nm.
-
Minecoside
Minecoside exhibits potent antioxidant activity.
